Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Issues»Volume 26, Issue 6»Association between high initial CEA, CA 19-9 levels and HER-2 status and their prognostic values on overall survival in metastatic gastric cancer
    Volume 26, Issue 6

    Association between high initial CEA, CA 19-9 levels and HER-2 status and their prognostic values on overall survival in metastatic gastric cancer

    December 1, 2021Updated:April 29, 20242 Mins Read
    Share
    Facebook Twitter Email

    Fatih Selcukbiricik1, Kayhan Erturk1, Emre Balık2, Buket Bayram Kuvvet3, Melisa Celayir3, Farid Babashov3, Deniz Tural4, Begum Guler Sentürk3, Nil Molinas Mandel1

    1Department of Medical Oncology, Koc University School of Medicine, Istanbul, Turkey.

    2Department of General Surgery, Koc University School of Medicine, Istanbul, Turkey.

    3Department of Internal Medicine, Koc University School of Medicine, Istanbul, Turkey.

    4Department of Medical Oncology, Bakirkoy Education and Research Hospital, Istanbul, Turkey.

    Summary

    Purpose: This study aimed to investigate the correlations between baseline levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) and immunohistochemical (IHC), Human epidermal growth factor receptor (HER-2) expressions; and question their prognostic values in patients with metastatic gastric cancer.

    Methods: Gastric cancer patients were retrospectively analyzed. Demographic information, clinical stages, immunohistochemical HER-2 expressions and serum CEA, serum CA 19-9 levels were evaluated at the time of diagnosis. The correlations between HER-2 IHC expressions and the initial marker levels were assessed, and survival analyses were performed.

    Results: A total of 411 patients were included in the study. Median age of patients was 58 years (range: 22-90); males: 297 (72.3%); females: 114 (27.7%). Median overall survival (OS) was 24 months (range: 19-29). Patient HER-2 IHC expression 0, 1, 2, 3 ratios were 43, 22, 16, and 19%, respectively. At the time of diagnosis, the median value of CEA was 4 (range: 3-5), and the median value of CA 19-9 was 18 (range: 14-22). The increase in CEA and CA 19-9 levels were correlated with the increase of IHC levels 1. OS of patients with high initial CEA levels (>5 ng/mL) were significantly shorter than those with low initial CEA levels (<5 ng/mL)1.

    Conclusion: Significant positive correlations were shown between HER-2 IHC expressions and CEA, CA 19-9 levels. Baseline CEA, CA 19-9 levels predicted HER-2 positivity and this directly affected treatment and OS.

    Key words: gastric cancer, CEA, CA 19-9, HER-2, IHC, survival.

    Full Text: PDF

    Original Article
    Previous ArticleComparison of response and survival of first-line crizotinib therapy according to EML-4 ALK fusion variants in advanced non-small cell lung cancer patients: A Turkish Oncology Group study
    Next Article Analysis on safety and efficacy of low-dose apatinib combined with paclitaxel as second-line treatment for advanced gastric cancer

    Related Articles

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    Volume 27, 2024

    Malignant Diseases as a Reason for Interventions by Emergency Medical Teams in Barajevo 2023

    Volume 27, 2024

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    Volume 26, Issue 6
    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.